Intrapatient variability of efavirenz concentrations as a predictor of virologic response to antiretroviral therapy. [electronic resource]
- Antimicrobial agents and chemotherapy Mar 2004
- 979-84 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0066-4804
10.1128/AAC.48.3.979-984.2004 doi
Adolescent Alkynes Anti-HIV Agents--adverse effects Area Under Curve Benzoxazines Child Child, Preschool Chromatography, High Pressure Liquid Cyclopropanes Female HIV Infections--drug therapy Humans Male Oxazines--adverse effects RNA, Viral--biosynthesis Regression Analysis Survival Analysis